• Mashup Score: 0

    Total annual costs associated with metastatic breast cancer in the U.S. could exceed $152 billion in 2030, according to a study published in JNCI Cancer Spectrum. Researchers attributed the estimated 2.4-fold increase from 2015 to a rise in cases among younger women.

    Tweet Tweets with this article
    • Costs of #MBC could jump 140% by 2030. The high cost of cancer care has led to #financialtoxicity for many; how can we reduce the cost? More research is needed to find the cause of de novo #mbc & early BrCa from metastasizing. .⁦@ProjectLifeMBC⁩ https://t.co/RUIpQ48a3F